• Summarize potassium homeostasis and hyperkalemia pathophysiology
  • Identify risk factors for and patient populations predisposed to chronic hyperkalemia
  • Differentiate appropriate potassium binder therapy based on patient specific factors and available literature
  • Identify outstanding gaps in data to be covered in future clinical trials
Session date: 
10/13/2020 - 11:30am to 12:30pm CDT
Will be determined by room availability. Primary location will be in the CSC. WebEx will be available for streaming.
600 Highland Ave
Madison, WI 53705
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Samantha Lewiston
Harpreet Sandhu
Katie Sherman